Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
Clinical trial NCT03616184 · COMPLETED
Trial details
- NCT number
- NCT03616184
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2022-01-22
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.